Receptor activator of nuclear factor-κB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase

Molecular Endocrinology

Volumn 22, Issue 3, 2008, Pages 737-750

  Fretz, Jackie A ^a   Shevde, Nirupama K ^a   Singh, Sujay ^b   Darnay, Bryant G ^c   Pike, J Wesley ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Imgenex Corporation   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; NUCLEAR FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RNA POLYMERASE II; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; AUTOREGULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; GENE TARGETING; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ACID PHOSPHATASE; ANIMALS; BLOTTING, WESTERN; BONE AND BONES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; HOMEOSTASIS; ISOENZYMES; MICE; MICE, INBRED C57BL; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PROMOTER REGIONS (GENETICS); RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 40849083845     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0333     Document Type: Article

References (45)

1. 2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun 246:337-341
2. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602
3. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T 2002 Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277:41147-41156
4. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901
5. Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF 2004 Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279:26475-26480
6. Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, Takayanagi H 2005 Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202:1261-1269
7. Serfling E, Berberich-Siebelt F, Chuvpilo S, Jankevics E, Klein-Hessling S, Twardzik T, Avots A 2000 The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta 1498:1-18
8. Hogan PG, Chen L, Nardone J, Rao A 2003 Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17:2205-2232
9. Chuvpilo S, Jankevics E, Tyrsin D, Akimzhanov A, Moroz D, Jha MK, Schulze-Luehrmann J, Santner-Nanan B, Feoktistova E, König T, Avots A, Schmitt E, Berberich-Siebelt F, Schimpl A, Serfling E 2002 Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16:881-895
10. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545
11. Zhou B, Cron RQ, Wu B, Genin A, Wang Z, Liu S, Robson P, Baldwin HS 2002 Regulation of the murine Nfatc1 gene by NFATc2. J Biol Chem 277:10704-10711
12. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A 1999 Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285:2129-2133
13. Beals CR, Clipstone NA, Ho SN, Crabtree GR 1997 Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev 11:824-834
14. Sun L, Moonga BS, Lu M, Zaidi N, Iqbal J, Blair HC, Epstein S, Abe E, Troen BR, Huang CL, Zaidi M 2003 Molecular cloning, expression, and function of osteoclastic calcineurin Aα. Am J Physiol Renal Physiol 284:F575-583
15. Hirotani H, Tuohy NA, Woo JT, Stern PH, Clipstone NA 2004 The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279:13984-13992
16. Kim Y, Sato K, Asagiri M, Morita I, Soma K, Takayanagi H 2005 Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem 280:32905-32913
17. Anusaksathien O, Laplace C, Li X, Ren Y, Peng L, Goldring SR, Galson DL 2001 Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene. J Biol Chem 276:22663-22674
18. Crotti TN, Flannery M, Walsh NC, Fleming JD, Goldring SR, McHugh KP 2006 NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiation. Gene 372:92-102
19. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV 2007 RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 313:168-178
20. Troen BR 2006 The regulation of cathepsin K gene expression. Ann NY Acad Sci 1068:165-172
21. Matsumoto M, Hisatake K, Nogi Y, Tsujimoto M 2001 Regulation of receptor activator of NF-κB ligand-induced tartrate-resistant acid phosphatase gene expression by PU. 1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor. J Biol Chem 276:33086-33092
22. Reddy SV, Hundley JE, Windle JJ, Alcantara O, Linn R, Leach RJ, Boldt DH, Roodman GD 1995 Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J Bone Miner Res 10:601-606
23. Wang ZQ, Liang J, Schellander K, Wagner EF, Grigoriadis AE 1995 c-fos-Induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. Cancer Res 55:6244-6251
24. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448
25. Wagner EF 2002 Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61(Suppl 2):40-42
26. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342
27. Chernukhin I, Shamsuddin S, Kang SY, Bergström R, Kwon YW, Yu W, Whitehead J, Mukhopadhyay R, Docquier F, Farrar D, Morrison I, Vigneron M, Wu SY, Chiang CM, Loukinov D, Lobanenkov V, Ohlsson R, Klenova E 2007 CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wide. Mol Cell Biol 27:1631-1648
28. Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, Engelhardt JF, Amendt BA 2005 PITX2, β-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci 118:1129-1137
29. 3. Mol Endocrinol 20:1231-1247
30. Delany I, Spohn G, Pacheco AB, Ieva R, Alaimo C, Rappuoli R, Scarlato V 2002 Autoregulation of Helicobacter pylori Fur revealed by functional analysis of the iron-binding site. Mol Microbiol 46:1107-1122
31. Acquaviva C, Salvat C, Brockly F, Bossis G, Ferrara P, Piechaczyk M, Jariel-Encontre I 2001 Cellular and viral Fos proteins are degraded by different proteolytic systems. Oncogene 20:942-950
32. Hohmann HP, Remy R, Scheidereit C, van Loon AP 1991 Maintenance of NF-κB activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol Cell Biol 11:259-266
33. Rice NR, Ernst MK 1993 In vivo control of NF-κB activation by I κ B α. EMBO J 12:4685-4695
34. Jakob F, Gieseler F, Tresch A, Hammer S, Seufert J, Schneider D 1992 Kinetics of nuclear translocation and turnover of the vitamin D receptor in human HL60 leukemia cells and peripheral blood lymphocytes - coincident rise of DNA-relaxing activity in nuclear extracts. J Steroid Biochem Mol Biol 42:11-16
35. Hoffmann A, Levchenko A, Scott ML, Baltimore D 2002 The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298:1241-1245
36. Gyling M, Leclercq G, Heuson JC 1990 Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms. J Recept Res 10:217-234
37. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T 2004 Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758-763
38. Mocsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC 2004 The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ-) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 101:6158-6163
39. Shevde NK, Bendixen AC, Dienger KM, Pike JW 2000 Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7829-7834
40. Shevde NK, Pike JW 1996 Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 87:2683-2692
41. Roodman GD 1999 Cell biology of the osteoclast. Exp Hematol 27:1229-1241
42. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 20:305-317
43. Oberley MJ, Farnham PJ 2003 Probing chromatin immunoprecipitates with CpG-island microarrays to identify genomic sites occupied by DNA-binding proteins. Methods Enzymol 371:577-596
44. Scacheri PC, Crawford GE, Davis S 2006 Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol 411:270-282
45. 3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J Biol Chem 278:31756-31765